AMS Narrows Q3 Loss, But YTD Profit Plunges on Acquisition Absence
Ticker: AMS · Form: 10-Q · Filed: Nov 14, 2025 · CIK: 744825
| Field | Detail |
|---|---|
| Company | American Shared Hospital Services (AMS) |
| Form Type | 10-Q |
| Filed Date | Nov 14, 2025 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 18 min |
| Sentiment | mixed |
Sentiment: mixed
Topics: Medical Equipment Leasing, Direct Patient Services, Radiosurgery, Proton Beam Therapy, International Expansion, Joint Ventures, Capital Expenditures
TL;DR
**AMS is burning cash on expansion, and without last year's acquisition boost, profits are in the red – proceed with caution.**
AI Summary
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported a net loss of $17,000 for the three months ended September 30, 2025, a significant improvement from the $207,000 net loss in the same period of 2024. However, for the nine months ended September 30, 2025, the company posted a net loss of $922,000, a sharp decline from the $3,514,000 net income in the prior year, largely due to the absence of a $3,942,000 bargain purchase gain from the RI Acquisition in 2024. Total revenues increased to $7,171,000 for the three-month period in 2025 from $6,999,000 in 2024, driven by a rise in direct patient services revenue to $4,034,000. For the nine-month period, total revenues grew to $20,354,000 from $19,271,000. Cash and cash equivalents decreased significantly from $11,025,000 at December 31, 2024, to $5,095,000 at September 30, 2025, primarily due to $9,618,000 in property and equipment purchases. The company also increased its current portion of long-term debt to $9,553,000 from $2,841,000 and drew $2,000,000 on its line of credit.
Why It Matters
For investors, the significant year-over-year decline in nine-month net income, from a $3.5 million profit to a $0.9 million loss, highlights the impact of one-time gains from the 2024 RI Acquisition. The substantial increase in capital expenditures for property and equipment, totaling $9,618,000, indicates a strategic investment in growth, but also contributed to the sharp decrease in cash. The competitive landscape in medical equipment leasing and direct patient services remains intense, and AMS's ability to generate sustainable profits without large acquisition gains will be crucial. Employees and customers will be watching how these investments translate into service expansion and stability, especially with new joint ventures in Mexico.
Risk Assessment
Risk Level: medium — The company's cash and cash equivalents plummeted from $11,025,000 to $5,095,000, a 53.8% decrease, within nine months, largely due to $9,618,000 in property and equipment purchases. This significant cash outflow, coupled with a net loss of $922,000 for the nine-month period, indicates potential liquidity strain if future investments don't yield expected returns quickly.
Analyst Insight
Investors should closely monitor AMS's cash flow and the profitability of its recent capital expenditures, particularly the $9,618,000 spent on property and equipment. Evaluate whether the new joint ventures in Mexico and the Rhode Island property acquisition will generate sufficient revenue to offset increased debt and operating costs, and consider the impact of future interest rate changes on its $9,553,000 current portion of long-term debt.
Financial Highlights
- debt To Equity
- 1.09
- revenue
- $7,171,000
- operating Margin
- N/A
- total Assets
- $59,629,000
- total Debt
- $18,165,000
- net Income
- -$17,000
- eps
- N/A
- gross Margin
- N/A
- cash Position
- $5,095,000
- revenue Growth
- +2.5%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Rental revenue from medical equipment leasing | $3,137,000 | -5.3% |
| Direct patient services revenue | $4,034,000 | +9.4% |
| Rental revenue from medical equipment leasing | $9,699,000 | -15.4% |
| Direct patient services revenue | $10,655,000 | +36.5% |
Key Numbers
- $17,000 — Net loss for Q3 2025 (Improved from $207,000 net loss in Q3 2024)
- $922,000 — Net loss for nine months ended Sept 30, 2025 (Compared to $3,514,000 net income in prior year, largely due to absence of bargain purchase gain)
- $7,171,000 — Total revenues for Q3 2025 (Increased from $6,999,000 in Q3 2024)
- $20,354,000 — Total revenues for nine months ended Sept 30, 2025 (Increased from $19,271,000 in prior year)
- $5,095,000 — Cash and cash equivalents at Sept 30, 2025 (Decreased from $11,025,000 at Dec 31, 2024)
- $9,618,000 — Payment for purchases of property and equipment (Significant cash outflow for nine months ended Sept 30, 2025)
- $9,553,000 — Current portion of long-term debt at Sept 30, 2025 (Increased from $2,841,000 at Dec 31, 2024)
- $2,000,000 — Line of credit balance at Sept 30, 2025 (New draw on line of credit compared to zero at Dec 31, 2024)
- 6,543,000 — Shares of common stock outstanding (As of November 11, 2025)
- $1,185,000 — Purchase price for real property in Bristol, RI (Acquired by subsidiary Bristol on February 6, 2025)
Key Players & Entities
- AMERICAN SHARED HOSPITAL SERVICES (company) — registrant
- GenesisCare USA, Inc. (company) — seller in RI Acquisition
- Elekta AB (company) — manufacturer of Gamma Knife
- NYSE AMERICAN (regulator) — exchange where AMS is registered
- FASB (regulator) — Financial Accounting Standards Board
- SEC (regulator) — Securities and Exchange Commission
- ASHS-Mexico, S.A. de C.V. (company) — subsidiary for international expansion
- Puebla (company) — joint venture in Mexico
- Hospital San Javier, S.A. de C.V. (company) — joint venture partner in Guadalajara, Mexico
- Bristol (company) — subsidiary that acquired real property
FAQ
What caused the significant drop in American Shared Hospital Services' nine-month net income for 2025?
The significant drop in American Shared Hospital Services' nine-month net income, from $3,514,000 in 2024 to a net loss of $922,000 in 2025, was primarily due to the absence of a $3,942,000 bargain purchase gain from the RI Acquisition that occurred in 2024.
How did American Shared Hospital Services' cash position change in the first nine months of 2025?
American Shared Hospital Services' cash and cash equivalents decreased significantly from $11,025,000 at December 31, 2024, to $5,095,000 at September 30, 2025. This $5,930,000 reduction was largely driven by $9,618,000 in payments for property and equipment purchases.
What were the key revenue drivers for American Shared Hospital Services in Q3 2025?
For the three months ended September 30, 2025, American Shared Hospital Services' total revenues increased to $7,171,000 from $6,999,000 in the prior year. This growth was primarily fueled by a rise in direct patient services revenue, which reached $4,034,000.
What strategic investments did American Shared Hospital Services make in 2025?
In 2025, American Shared Hospital Services made several strategic investments, including the acquisition of real property in Bristol, Rhode Island, for $1,185,000 by its subsidiary Bristol on February 6, 2025. The company also continued its international expansion with joint ventures in Mexico, such as Puebla, which began treating patients in July 2024, and a new joint venture with Hospital San Javier, S.A. de C.V. in Guadalajara, Mexico, expected to begin treating patients in Q2 2026.
What is the status of American Shared Hospital Services' international expansion efforts?
American Shared Hospital Services is actively expanding internationally through subsidiaries like ASHS-Mexico. Its joint venture Puebla in Mexico began treating patients in July 2024, and a new joint venture with Hospital San Javier, S.A. de C.V. in Guadalajara, Mexico, is expected to commence patient treatment in the second quarter of 2026.
How has American Shared Hospital Services' debt profile changed?
American Shared Hospital Services' current portion of long-term debt significantly increased to $9,553,000 at September 30, 2025, from $2,841,000 at December 31, 2024. Additionally, the company drew $2,000,000 on its line of credit, which was zero at the end of 2024.
What are the future accounting standard updates that could impact American Shared Hospital Services?
American Shared Hospital Services is evaluating several future accounting standard updates. ASU 2023-09 (Income Taxes) will modify disclosures for annual periods beginning after December 15, 2024. ASU 2024-03 (Income Statement - Reporting Comprehensive Income) will require new expense disaggregation disclosures for annual periods beginning after December 15, 2026. ASU 2025-05 (Measurement of Credit Losses) will provide practical expedients for estimating credit losses for accounts receivable, effective for annual periods beginning after December 15, 2025.
What is American Shared Hospital Services' strategy for growth in the medical equipment sector?
American Shared Hospital Services' growth strategy involves both domestic and international expansion. Domestically, it provides Gamma Knife units to seven medical centers in the United States through GKF and acquired real property in Bristol, RI, for $1,185,000. Internationally, it's expanding through subsidiaries like ASHS-Mexico, with joint ventures in Puebla and Guadalajara, Mexico, to provide radiation therapy and radiosurgery services.
What is the current ownership structure of American Shared Hospital Services' key subsidiaries?
American Shared Hospital Services wholly owns subsidiaries such as American Shared Radiosurgery Services (ASRS), PBRT Orlando, LLC, and ASHS-Mexico, S.A. de C.V. It holds majority ownership in Southern New England Regional Cancer Center, LLC (60%), Roger Williams Radiation Therapy, LLC (60%), and Long Beach Equipment, LLC. ASRS is the majority owner of GK Financing, LLC (GKF), which in turn has majority ownership in Albuquerque GK Equipment, LLC and Jacksonville GK Equipment, LLC.
How does American Shared Hospital Services recognize its revenue from medical equipment leasing?
American Shared Hospital Services recognizes revenue from medical equipment leasing under ASC 842, either on a fee per use or revenue sharing basis, when services are rendered and collectability is reasonably assured. Fee per use revenues are recognized when procedures are performed based on contracted rates, while revenue sharing arrangements involve receiving a contracted percentage of hospital reimbursements, estimated based on historical experience.
Industry Context
The healthcare services industry, particularly those providing shared hospital services, operates in a highly regulated environment with significant capital expenditure requirements. Companies in this sector often face pressures related to reimbursement rates, technological advancements, and the need for efficient asset utilization. Competition can arise from other shared service providers, in-house hospital departments, and specialized medical equipment leasing companies.
Regulatory Implications
As a provider of healthcare services, AMS is subject to various federal and state regulations, including those related to patient care, billing, and data privacy (e.g., HIPAA). Changes in healthcare policy, reimbursement models (like Medicare/Medicaid), or increased compliance burdens could materially impact the company's financial performance and operational costs.
What Investors Should Do
- Monitor the trend in direct patient services revenue
- Analyze the drivers of increased debt and decreased cash
- Evaluate the impact of the absence of the bargain purchase gain
Key Dates
- 2025-09-30: End of Q3 2025 — Company reported a net loss of $17,000 on revenues of $7,171,000, with cash and cash equivalents at $5,095,000.
- 2024-09-30: End of Q3 2024 — Company reported a net loss of $207,000 on revenues of $6,999,000.
- 2025-12-31: End of Fiscal Year 2024 — Company had cash and cash equivalents of $11,025,000 and total debt of $20,182,000.
- 2025-02-06: Acquisition of real property in Bristol, RI — A subsidiary acquired property for $1,185,000, contributing to the increase in property and equipment.
Glossary
- Bargain Purchase Gain
- A gain recognized when a company acquires another business for a price lower than the fair value of its net identifiable assets. (The absence of a $3,942,000 bargain purchase gain from the RI Acquisition in 2024 significantly impacted the year-over-year net income comparison for the nine-month period.)
- Right of use assets, net
- Assets recognized under lease accounting standards, representing the right to use an underlying asset for the lease term. (These assets increased significantly from $1,015,000 at December 31, 2024, to $3,750,000 at September 30, 2025, indicating new lease agreements or changes in lease terms.)
- Current portion of long-term debt
- The amount of long-term debt that is due within the next year. (This has increased substantially from $2,841,000 at December 31, 2024, to $9,553,000 at September 30, 2025, suggesting a shift in debt maturity or new short-term financing.)
- Line of credit
- A flexible loan that allows a borrower to draw funds up to a certain limit, repay them, and then borrow again. (The company drew $2,000,000 on its line of credit by September 30, 2025, indicating increased reliance on short-term borrowing.)
Year-Over-Year Comparison
Compared to the prior year's nine-month period, AMERICAN SHARED HOSPITAL SERVICES has seen a significant shift from net income of $3,514,000 to a net loss of $922,000, largely due to the absence of a substantial bargain purchase gain. While total revenues have grown from $19,271,000 to $20,354,000, driven by a strong increase in direct patient services revenue, this has not been enough to offset the one-time gain's impact. The company's financial position has also changed, with cash reserves nearly halving from $11,025,000 to $5,095,000 due to significant investments in property and equipment, alongside a notable increase in short-term debt obligations.
Filing Stats: 4,466 words · 18 min read · ~15 pages · Grade level 16.5 · Accepted 2025-11-14 13:04:24
Filing Documents
- asha20250930_10q.htm (10-Q) — 1140KB
- ex_885927.htm (EX-10.1) — 41KB
- ex_855253.htm (EX-31.1) — 7KB
- ex_855254.htm (EX-31.2) — 8KB
- ex_855255.htm (EX-32.1) — 6KB
- 0001437749-25-035088.txt ( ) — 6576KB
- ams-20250930.xsd (EX-101.SCH) — 62KB
- ams-20250930_cal.xml (EX-101.CAL) — 49KB
- ams-20250930_def.xml (EX-101.DEF) — 397KB
- ams-20250930_lab.xml (EX-101.LAB) — 345KB
- ams-20250930_pre.xml (EX-101.PRE) — 427KB
- asha20250930_10q_htm.xml (XML) — 1091KB
– FINANCIAL INFORMATION
PART I – FINANCIAL INFORMATION
Financial Statements
Item 1. Financial Statements AMERICAN SHARED HOSPITAL SERVICES CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) ASSETS September 30, 2025 December 31, 2024 Current assets: Cash and cash equivalents $ 5,095,000 $ 11,025,000 Restricted cash 250,000 250,000 Accounts receivable, net of allowance for credit losses of $ 380,000 and $ 265,000 at September 30, 2025 and at December 31, 2024 11,806,000 11,610,000 Tax receivables 1,363,000 550,000 Other receivables 545,000 495,000 VAT receivable 904,000 8,000 Prepaid maintenance 42,000 1,392,000 Prepaid expenses and other current assets 586,000 928,000 Total current assets 20,591,000 26,258,000 Property and equipment, net 32,285,000 31,125,000 Land 1,305,000 19,000 Goodwill 1,265,000 1,265,000 Intangible asset 78,000 78,000 Right of use assets, net 3,750,000 1,015,000 Other assets 355,000 437,000 Total assets $ 59,629,000 $ 60,197,000 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 1,107,000 $ 1,562,000 Employee compensation and benefits 593,000 1,368,000 Other accrued liabilities 2,069,000 1,888,000 Related party liabilities 521,000 1,320,000 Asset retirement obligations, related party (includes $ 250,000 and $ 250,000 non-related party at September 30, 2025 and December 31, 2024) 1,200,000 1,200,000 Current portion of lease liabilities 128,000 226,000 Line of credit 2,000,000 - Current portion of long-term debt, net 9,553,000 2,841,000 Total current liabilities 17,171,000 10,405,000 Long-term lease liabilities, less current portion 4,304,000 1,500,000 Long-term debt, net, less current portion 8,631,000 17,341,000 Deferred income taxes 924,000 924,000 Total liabilities 31,030,000 30,170,000 Commitments (see Note 8) Shareholders' equity: Common stock, no par value ( 10,000,000 authorized shares; Issued and outstanding shares - 6,510,000 at September 30, 2025 and 6,420,000 at December 31, 20